These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1808404)

  • 1. [A new peripheral vasodilator prostaglandin E1 in atherosclerosis of lower limb vessels and Raynaud disease].
    Kirichenko AA; Novichkova IuN; Zubkova LV; Ter-Gevondian NM; Nenakhova TV
    Klin Med (Mosk); 1991 Nov; 69(11):40-3. PubMed ID: 1808404
    [No Abstract]   [Full Text] [Related]  

  • 2. Recount of prostaglandin E1 therapy in a patient with Raynaud's phenomenon.
    DiGiovanni RL; Littlefield JM; Good RG
    J Am Osteopath Assoc; 1995 Oct; 95(10):572. PubMed ID: 8557544
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prostaglandin E1 in the treatment of chronic ischemia of the extremities].
    Kowal-Gierczak B; Kurzawska-Mielecka M; Czarnacki M
    Pol Arch Med Wewn; 1990 Nov; 84(5):321-7. PubMed ID: 2075125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of peripheral arterial insufficiency with inositoli nicotinas (Hexanicit).
    Hentzer E
    Scand J Clin Lab Invest Suppl; 1967; 99():226-32. PubMed ID: 4862834
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prostaglandin E1 in treatment of incomplete ischemia syndromes of the lower extremity].
    Vogelpohl M; Nobbe F
    Vasa Suppl; 1991; 32():377-82. PubMed ID: 1771539
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of surheme on improved blood flow in limbs].
    Wesolowski J; Hubl S; Godziemba-Maliszewska E
    Wiad Lek; 1972 Jul; 25(14):1297-300. PubMed ID: 5054661
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostanoids for chronic critical leg ischemia. A randomized, controlled, open-label trial with prostaglandin E1. The ICAI Study Group. Ischemia Cronica degli Arti Inferiori.
    Ann Intern Med; 1999 Mar; 130(5):412-21. PubMed ID: 10068415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy evaluation of prostaglandin E1 against placebo in patients with progressive systemic sclerosis and significant Raynaud's phenomenon.
    Bartolone S; Trifiletti A; De Nuzzo G; Scamardi R; Larosa D; Sottilotta G; Raffa A; Barbera N
    Minerva Cardioangiol; 1999 May; 47(5):137-43. PubMed ID: 10479851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of Hexanicotol (inositol niacinate) in peripheral vascular disease.
    Heather AJ
    Del Med J; 1967 Feb; 39(2):33-8. PubMed ID: 5341473
    [No Abstract]   [Full Text] [Related]  

  • 10. EDTA chelation as a treatment of arteriosclerosis.
    Godfrey ME
    N Z Med J; 1990 Apr; 103(887):162-3. PubMed ID: 2111528
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical experience with bencyclane in the treatment of vascular obliterations in the limbs].
    Krakovskij NI; Taranovic VA
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1435+. PubMed ID: 5536665
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of the treatment of peripheral arterial diseases with PGE1].
    Borkowski M; Kruk M; Królicki L; Wojtal E; Malmurowicz L; Górewicz R; Laszuk D
    Pol Tyg Lek; 1990 Jun 18-25; 45(25-26):505-8. PubMed ID: 2287566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of vasospastic disease with prostaglandin E1.
    Clifford PC; Martin MF; Sheddon EJ; Kirby JD; Baird RN; Dieppe PA
    Br Med J; 1980 Oct; 281(6247):1031-4. PubMed ID: 7427564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with prostaglandin E1 in the treatment of arteriosclerosis obliterans. A preliminary report.
    Ambrus JL; Taheri P; Killion D; Donaldson G
    J Med; 1983; 14(1):1-15. PubMed ID: 6577118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E1 from the tip of an intraaortic balloon catheter for lower limb ischemia.
    Nakano T; Tominaga R; Shiraishi K; Yasui H
    Ann Thorac Surg; 1998 Apr; 65(4):1158-60. PubMed ID: 9564956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of Raynaud's phenomenon with limaprost, an oral prostaglandin E1 analogue.
    Tsukamoto H; Nagasawa K
    Br J Rheumatol; 1991 Aug; 30(4):317. PubMed ID: 1863837
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intravenous laser irradiation of the blood in occlusive vascular diseases of the extremities].
    Shval'b PG; Zakharchenko AIa; Sigaev AA; Kataev MI
    Sov Med; 1990; (3):21-3. PubMed ID: 2367895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of abnormal blood flow and efficacy of treatment in patients with systemic sclerosis using a newly developed microwireless laser Doppler flowmeter and arm-raising test.
    Kido M; Takeuchi S; Hayashida S; Urabe K; Sawada R; Furue M
    Br J Dermatol; 2007 Oct; 157(4):690-7. PubMed ID: 17640308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prostaglandin E1 in the treatment of chronic advanced ischemia of the legs before amputation. Mid-term results].
    Fernández-Miranda E; Latorre C; Gil Vera F; González Mate A; Olmos A; Petit J; Durán H
    Rev Quir Esp; 1988; 15(2):67-70. PubMed ID: 3153367
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the effect of alpha- and of beta-adrenergic blocking agents on the circulation in human limbs.
    Clement DL
    Verh K Acad Geneeskd Belg; 1980; 42(3-4):164-214. PubMed ID: 6114601
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.